RecruitingNot ApplicableNCT06569667

Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Leveraging Social Determinants Via Artificial Intelligence and Peer Coaching to Address Racial Disparities in Primary Care Among People Who Use Opioids

Sponsor

Friends Research Institute, Inc.

Enrollment

292 participants

Start Date

Mar 28, 2025

Study Type

INTERVENTIONAL

Summary

Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that delivers social services, stigma reduction, health habitus, and patient navigation content addressing social determinants of health to enhance receipt of buprenorphine in primary care among emergency department-enrolled Black / Latinx people who use opioids.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria10

≥18 years of age;
fluent in English and/or Spanish;
self-reported non-prescription opioid use <30 days prior to consent;
provision of informed consent;
planned stay in NYC ≥12 month;
self-identified Black and/or Latinx race/ethnicity;
positive urine toxicology for opioids per EMR records;
diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5
self-reported interest in initiating buprenorphine in primary care
must have a mobile phone data plan.

Exclusion Criteria3

inability to comprehend text content written at a 3rd grade reading level;
physical or visual disability preventing mobile phone use;
self-reported receipt of medications for OUD in past 30 days.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPRC supported text + AI driven SDH-enhanced text

This interventional study evaluates an AI-driven texting tool combined with peer recovery coach support to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.

BEHAVIORALAI driven SDH-enhanced text only

This interventional study evaluates an AI-driven SDH-enhanced texting tool to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.

BEHAVIORALTreatment as Usual (TAU)

Control Arm-3 will receive treatment as usual (i.e., verbal instructions, NYC Dept of Health pamphlets detailing access to OUD and social services, health system smartphone application EMR patient portal).

Locations(1)

NYC Health + Hospitals

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06569667